FreeStride Therapeutics, Inc

We’re a developing a drug for veterinary bone/joint disorders; a $2.5B+potential market. We are seeking $1M to show clinical efficacy needed for FDA approval.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Ann Arbor, MI, US
  • Currency USD
  • Founded August 2009
  • Employees 4
  • Website None

Company Summary

FreeStride’s drug restores bone health by preventing both inflammation and bone loss. Targets are periostitis in horses & OA in dogs/cats. Working with The Center for Veterinary Medicine, FreeStride received a fee waiver (~$1.1M) based on qualifying for the MUMS program in horses (similar to the Orphan Disease program for humans). FDA approval will take 32 mo. (post money) FreeStride has a lead investor and are currently syndicating this deal

Team

  • Chief Operations Officer

    Has 13 years of startup experience; founded 3 biotech companies, recruited and built management teams, business development and licensing functions; raised > $27M in capital; created successful strategic and developmental partnerships; developed and led clinical trials teams through two successful IND applications and the successful completion of a Phase I clinical trial. Dr. Long co-founded FreeStride and is the company’s operational manager.

  • President & Acting CEO

    More than 16 years of startup experience; co-founded 6 biotech start-ups; helped raise more than $61M in private capital and public funding. He was a founding member of Accuri Cytometers Inc. (recently acquired for $206M by BD Biosciences). Dr. Olson is a co-founder of FreeStride and has established the corporate strategy and been the lead for fund raising activities.

  • Chief Marketing & Sales Officer

    Has 14 years startup experience; Key roles: Director of Marketing HealthMedia Inc., VP of Marketing Healtheon/WebMD, Senior Market Research Analyst Baylor Healthcare. Responsibilities included: strategic planning, brand and campaign management, product marketing, market launch, communications & advertising, new market development, and public relations. Ms Bashshur is a co-founder of FreeStride and is the company’s Chief Marketing & Sales Officer

  • Chief Financial Officer

    Has 18 years of startup experience; 10 years in life sciences. industry. As Director of Finance at Atterocor he established and led the financial operations of the company from inception through seed and Series A ($16M) fund raising. Eric holds an MBA with a concentration in Finance and Corporate Strategy and is a licensed CPA in the state of California.

Advisors

  • Alicia Bertone, DVM, PhD
    Diplomat ACVS; Trueman Chair in Equine Clinical Medicine and Surgery, Director Comparative Orthopedic Research Lab, College of Veterinary Medicine, The Ohio State University. World-renowned thought leader in the field of equine orthopedic surgery
    Unconfirmed
    Ralph Claxton MS, DVM
    Director Regulatory Affairs Shafer Veterinary Consultants has over 20 years experience in clinical trials, product manufacturing, veterinary research, and regulatory affairs for the development of animal drugs.
    Unconfirmed

Previous Investors

  • Jeff Sloan
    Managing Partner Aria Ventures; Angel Investor in FreeStride
    Unconfirmed
    Stephen Haakenso
    Executive Director, Biosciences Research & Commercialization Center Establishedby the Michigan Legislature, the BRCC provides startup funding to promising Michigan-based life sciences ventures entering the commercialization phase of development.
    Unconfirmed
    Senior Vice President, Ann Arbor economic development (SPARK) Provides funding for start-ups to assist with operational needs such as consultants, payroll, equipment, technology deployment and commercialization efforts is critical to business growth.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free